CRISPR-Cas enzyme-based diagnostics to detect SARS-CoV-2 infection

A recent review in the journal Life provided a detailed description of CRISPR-Cas-based diagnostic techniques to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but also emphasized the potential use of this technology towards developing effective molecular diagnostic platforms for any future pandemic.

Related Keywords

Seoul ,Soult Ukpyolsi ,South Korea ,Sangha Kwon ,Yurchanka Siarhei Shutterstock ,Konkuk University ,Cas Effector Enzyme Based Diagnostics ,Infectious Diseases ,Yurchanka Siarhei ,Image Credit ,Coronavirus Disease Covid 19 ,Rispr ,Iagnostics ,Nzyme ,Cars ,Ars Cov 2 ,Archaea ,Bacteria ,Cas13 ,Cas9 ,Chip ,Coronavirus ,Iagnostic ,Na ,Luorescence ,Enetic ,Enome ,Genome Editing ,Palindromic Repeats ,Pandemic ,Eagents ,Espiratory ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Yndrome ,